Pharmakonzern · Israel
Teva
Ein Konzern aus 104 Unternehmen: 5.969 Arzneimittel, verteilt auf 12 Länder.
Konzernstruktur
104 Unternehmen, verteilt auf 31 Länder
Wird geladen …
Pharmakonzern · Israel
Ein Konzern aus 104 Unternehmen: 5.969 Arzneimittel, verteilt auf 12 Länder.
104 Unternehmen, verteilt auf 31 Länder
Ein kostenloses Konto für die Prognia-Apps: Ward zum Lernen, Osler für klinische Antworten mit ihren Quellen und das Netzwerk, um deine Kolleginnen und Kollegen zu finden.
Prognia stellt Konzerne aus den Namen zusammen, die Behörden veröffentlichen, und aus Verknüpfungen zwischen Unternehmen; sie sind keine offizielle Konzernstruktur.
Alle Arzneimittel aller Unternehmen im Konzern, aktuelle zuerst.
1–25 von 5.969
| Arzneimittel | Wirkstoff | Land | Status | Zulassung |
|---|---|---|---|---|
| ABACAVIR/LAMIVUDINA TEVA 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG600 mg + 300 mg · Comprimido recubierto con película | Abacavir, Lamivudine | Spanien | Im Handel | 2016 |
| Abacavir/Lamivudine Teva 600/300 mg, filmomhulde tablettenFilmomhulde tablet | Abacavir, Lamivudine | Niederlande | Zugelassen | 2016 |
| Abakavir/lamivudin Pliva 600 mg/300 mg filmom obložene tablete*filmom obložena tableta | Abacavir, Lamivudine | Kroatien | Nicht im Handel | 2020 |
| Abelcet lipid complex 5 mg/ml koncentrat za disperziju za infuziju*koncentrat za disperziju za infuziju | Amphotericin b | Kroatien | Nicht im Handel | 2019 |
| Abirateron Teva500mg · film tableta | Abiraterone | Serbien | Zugelassen | 2023 |
| Abirateron Teva500mg · film tableta | Abiraterone | Serbien | Zugelassen | 2023 |
| Abirateron Teva500mg · film tableta | Abiraterone | Serbien | Zugelassen | 2023 |
| Abirateron Teva 500 mg filmom obložene tableteFilmom obložena tableta | Abiraterone | Kroatien | Im Handel | 2022 |
| Abirateron Teva 500 mg, filmomhulde tablettenFilmomhulde tablet | Abiraterone | Niederlande | Zugelassen | 2022 |
| ABIRATERONE-TEVA FC TABLET 250 MG250 mg · Tablet, film coated | Abiraterone | Singapur | Zugelassen | 2022 |
| ABIRATERONE-TEVA FC TABLET 500 MG500 mg · Tablet, film coated | Abiraterone | Singapur | Zugelassen | 2024 |
| ACETAMINOPHEN325 mg · Tablet | Paracetamol | Kanada | Zugelassen | |
| ACETAMINOPHEN AND CODEINE PHOSPHATE300mg; 15mg | 300mg; 30mg | 300mg; 60mg · Capsule | Paracetamol, Codeine | Vereinigte Staaten | Nicht im Handel | 1983 |
| ACETAMINOPHEN EXTRA STRENGTH500 mg · Tablet | Paracetamol | Kanada | Zugelassen | |
| ACETAMINOPHEN WITH CODEINE - CAPLET300 mg + 15 mg + 8 mg · Tablet | Paracetamol, Caffeine, Codeine | Kanada | Im Handel | 1997 |
| ACETASOL2% · Solution/drops | Acetic acid, Glacial | Vereinigte Staaten | Nicht im Handel | 1981 |
| ACETASOL HC2%; 1% · Solution/drops | Acetic acid, Glacial, Hydrocortisone | Vereinigte Staaten | Nicht im Handel | 1982 |
| acetato de abiraterona | Abiraterone | Brasilien | Zugelassen | 2020 |
| acetato de glatirâmer | Glatiramer acetate | Brasilien | Zugelassen | 2023 |
| ACETILCISTEINA TEVA-RATIOPHARM 200 MG POLVO PARA SOLUCION ORAL EFG200 mg · Polvo para solución oral | Acetylcysteine | Spanien | Im Handel | 2000 |
| ACETILCISTEINA TEVA-RATIOPHARM 600 mg COMPRIMIDOS EFERVESCENTES EFG600 mg · Comprimido efervescente | Acetylcysteine | Spanien | Im Handel | 2000 |
| Acetylcysteine bruis Teva 200 mg, bruistablettenBruistablet | Acetylcysteine | Niederlande | Zugelassen | 1992 |
| Acetylcysteine bruis Teva 600 mg, bruistablettenBruistablet | Acetylcysteine | Niederlande | Zugelassen | 1992 |
| Acetylcysteïne Teva 200 mg, poeder voor oraal gebruikPoeder voor oraal gebruik | Acetylcysteine | Niederlande | Zugelassen | 1988 |
| Acetylcysteïne Teva 600 mg, poeder voor oraal gebruikPoeder voor oraal gebruik | Acetylcysteine | Niederlande | Zugelassen | 1990 |
Wo es Zulassungen hält oder Arzneimittel herstellt, und wie viele davon aktuell sind.
| Land | Arzneimittel | Aktuell | Früher | Unternehmen |
|---|---|---|---|---|
| Kanada | 1.853 | 708 | 1.145 | UnternehmenAlle Arzneimittel |
| Spanien | 1.382 | 903 | 479 | UnternehmenAlle Arzneimittel |
| Niederlande | 1.072 | 1.072 | 0 | UnternehmenAlle Arzneimittel |
| Kroatien | 414 | 414 | 0 | UnternehmenAlle Arzneimittel |
| Serbien | 326 | 319 | 7 | UnternehmenAlle Arzneimittel |
| Vereinigte Staaten | 313 | 283 | 30 | UnternehmenAlle Arzneimittel |
| Rumänien | 227 | 0 | 227 | UnternehmenAlle Arzneimittel |
| Singapur | 149 | 149 | 0 | UnternehmenAlle Arzneimittel |
| Europäische Union (EMA) | 105 | 62 | 43 | UnternehmenAlle Arzneimittel |
| Brasilien | 72 | 41 | 31 | UnternehmenAlle Arzneimittel |
| Saudi-Arabien | 54 | 54 | 0 | UnternehmenAlle Arzneimittel |
| Italien | 2 | 2 | 0 | UnternehmenAlle Arzneimittel |
Auch registriert in: Australien, Deutschland, Ecuador, Frankreich, Kolumbien, Malaysia, Schweden, Vereinigtes Königreich
Die ATC-Gruppen, zu denen die meisten seiner Arzneimittel gehören, größte zuerst.
Die Wirkstoffe in den meisten seiner Arzneimittel.
Wie die Register den Namen schreiben, normalisiert: ohne Rechtsform, Akzente und Großbuchstaben.
Von Prognia aus den unten genannten öffentlichen Arzneimittel- und Unternehmensregistern zusammengestellt. Logos werden nicht verwendet.
Prognia stellt Konzerne aus den Namen zusammen, die Behörden veröffentlichen, und aus Verknüpfungen zwischen Unternehmen; sie sind keine offizielle Konzernstruktur.
Source: European Medicines Agency (EPAR data).
Lizenz: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Lizenz: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Lizenz: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Lizenz: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Lizenz: Creative Commons Attribution 3.0 Australia
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Lizenz: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Lizenz: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Lizenz: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Lizenz: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Lizenz: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Lizenz: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Lizenz: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Lizenz: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Lizenz: CC BY-SA 4.0
Czech Ministry of Finance, ARES; Ministry of Justice commercial register (VR), Czech Statistical Office (RES), exact IČO, source record datumAktualizace and retrieval date. Structured extraction by Prognia.
Lizenz: Czech statutory open data; ARES reuse and operating terms
Bundesinstitut für Arzneimittel und Medizinprodukte, pediatric list, acquired 2026-10-29T14:36:58.614273+00:00
Lizenz: commercial redistribution permission not established
Bundesinstitut für Arzneimittel und Medizinprodukte, urgent list, acquired 2026-10-29T14:36:58.856157+00:00
Lizenz: commercial redistribution permission not established
Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), published shortage reports CSV, retrieved 2026-10-28.
Lizenz: commercial redistribution permission not established
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria (ARCSA), caducados report, acquired 2026-10-29T19:40:11.852118+00:00
Lizenz: commercial redistribution permission not established
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria (ARCSA), suspendidos_cancelados report, acquired 2026-10-29T19:40:39.796625+00:00
Lizenz: commercial redistribution permission not established
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria (ARCSA), vigentes report, acquired 2026-10-29T19:39:28.336494+00:00
Lizenz: commercial redistribution permission not established
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Lizenz: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Lizenz: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Lizenz: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Lizenz: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Lizenz: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Lizenz: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Lizenz: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Lizenz: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
GLEIF; exact source URL and retrieval date; no endorsement.
Lizenz: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Lizenz: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
AIFA, https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv, HTTP Last-Modified Mon, 26 Oct 2026 00:02:13 GMT, acquired 2026-10-26T09:43:33.749886+00:00; factual native values retained; exact row correspondence and projections are adaptations.
Lizenz: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Lizenz: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Lizenz: Italian Open Data Licence
State Enterprise Centre of Registers / Valstybės įmonė Registrų centras; source dataset/resource URL, exact original code/UUID/revision, original CSV ordinal, retrieval time; CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; selected field normalization by Prognia.
Lizenz: Creative Commons Attribution
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Lizenz: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Lizenz: Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0)
Oficiul Național al Registrului Comerțului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Lizenz: Creative Commons Attribution
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Lizenz: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Lizenz: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Lizenz: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Lizenz: Singapore Open Data Licence
Register právnických osôb, podnikateľov a orgánov verejnej moci; public API licence names Štatistický úrad Slovenskej republiky; administration transferred to Ministerstvo vnútra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.
Lizenz: Creative Commons Attribution
Slovak Ministry of Finance, Register účtovných závierok (RÚZ) Open API; exact IČO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.
Lizenz: CC0
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Lizenz: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Fehler melden oder Entfernung beantragenKorrekturen vom Unternehmen selbst sind willkommen.
Halten Sie die Arzneimittel von Teva auf Prognia korrekt, sehen Sie, wie Fachleute sie nutzen, und beantworten Sie ihre Fragen. Ein 20-minütiges Gespräch, auf Englisch.
Gespräch buchenBekannte Pharmakonzerne, jeweils mit allen Unternehmen.